Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

If you need to get a hold of Josh Pyke early next year, good luck to you — he'll be everywhere but home. Today, the beloved Australian singer-songwriter has announced he'll extend his hugely ...

You may have noticed an officer standing just behind the President of India at official events, state visits, or ceremonial functions. That officer holds a very important role as an Aide-de-Camp (ADC) ...

Julia Pyke has fended off judicial reviews and staunch local opposition, and waded through Britain’s unwieldy Treasury ‘Green Book’ process to get Sizewell C commissioned by the government. Now, she ...

Truro City have signed former Grimsby Town striker Rekeil Pyke on a one-year deal. The 27-year-old former Shrewsbury Town striker left the Mariners after two seasons earlier this summer. He played ...

While the race is on to develop antibody-drug conjugate (ADC) cancer treatments, so too is the competition to manufacture them. Hoping to gain an edge in the rapidly growing market are MilliporeSigma ...

Blaise Christoper Baddeley and Dane Ronald Pyke have been found not guilty of murdering Dean Jupp at his home in north-west Tasmania. According to a forensic pathologist, Mr Jupp died from "blunt ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Julia Pyke is on a mission to show the nuclear industry is filled with “nice, normal people”. As joint managing ...

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...

LoL Patch 14.21 has been here for a while and it's huge. It brought lots of buffs and nerfs to League of Legends champions. Of course, this shook up the meta a lot. In this article we will list the ...